Public Pharma for Europe: the Case of CAR-T Cell Therapy
Date/Time
Date(s) - 19/09/2024
15:00 GMT+0200 - 16:00 GMT+0200
Categories
On far too many occasions, publicly funded medical research that leads to successful health technologies fails to prioritise global access in licensing and marketing strategies. As public research institutions lead the development of CAR-T therapies, these groundbreaking therapies offer a new opportunity for the public sector to contribute to more globally equitable and just pharmaceutical policies.
We invite you to hear from researchers, advocates, and academics as we address the main challenges to scaling up CAR-T therapies’ development and production in the public sector. We will also explore how conducive regulatory frameworks can protect and advance the public interest. Overall, we encourage you to engage in a discussion that will shape the future of access to health technologies for years to come.
Register now to take part: https://us02web.zoom.us/webinar/register/WN_U-W9Eg6LT-iIiAp2vOSd6g
